Hot Pursuit     12-Oct-23
Zydus Lifesciences Ltd down for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 595.5, down 0.73% on the day as on 13:19 IST on the NSE. The stock jumped 43.58% in last one year as compared to a 16.4% rally in NIFTY and a 18.05% spurt in the Nifty Metal index.

Zydus Lifesciences Ltd is down for a fifth straight session today. The stock is quoting at Rs 595.5, down 0.73% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.04% on the day, quoting at 19803.9. The Sensex is at 66445.78, down 0.04%.Zydus Lifesciences Ltd has lost around 7.42% in last one month.Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has eased around 1.68% in last one month and is currently quoting at 15176.6, up 0.09% on the day. The volume in the stock stood at 6.05 lakh shares today, compared to the daily average of 14.53 lakh shares in last one month.

The benchmark October futures contract for the stock is quoting at Rs 597.15, down 0.65% on the day. Zydus Lifesciences Ltd jumped 43.58% in last one year as compared to a 16.4% rally in NIFTY and a 18.05% spurt in the Nifty Metal index.

The PE of the stock is 28.35 based on TTM earnings ending June 23.

Previous News
  Indices trade higher; consumer durable shares rally
 ( Market Commentary - Mid-Session 22-Apr-24   13:37 )
  Sensex gains 239 pts; metal shares shine; VIX rallies 3.35%
 ( Market Commentary - Mid-Session 31-Jul-24   12:33 )
  Zydus Life edges higher after launching OAB treatment drug Mirabegron in US
 ( Hot Pursuit - 22-Apr-24   09:25 )
  Zydus Life gets tentative USFDA nod for hypertension drugs
 ( Hot Pursuit - 14-Jun-24   12:34 )
  Zydus receives USFDA approval for Enzalutamide capsules
 ( Corporate News - 28-Sep-24   14:21 )
  Zydus receives Mexican regulatory approval for breast cancer drug
 ( Corporate News - 31-Jul-24   14:00 )
  Torrent Pharmaceuticals and Zydus enter in licensing agreement for co-marketing Saroglitazar Magnesium
 ( Corporate News - 10-Nov-23   16:04 )
  Zydus Life launches cancer drug in India
 ( Hot Pursuit - 13-Mar-24   16:06 )
  Sentynl receives marketing authorisation for NULIBRY® from UK MHRA
 ( Corporate News - 20-Apr-24   17:21 )
  Zydus Lifesciences receives USFDA approval for Ivabradine Tablets
 ( Corporate News - 01-Dec-23   12:32 )
  Zydus Lifesciences launches cancer drug - IBYRA in India
 ( Corporate News - 13-Mar-24   16:31 )
Other Stories
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
Back Top